X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10) 10
hepatitis c virus (9) 9
humans (8) 8
cell line (6) 6
cells (5) 5
hepacivirus - physiology (5) 5
occludin (5) 5
b type-i (4) 4
caffeic acid (4) 4
hepacivirus - drug effects (4) 4
hepatocytes - virology (4) 4
pharmacology & pharmacy (4) 4
replication (4) 4
virology (4) 4
antiviral agents - pharmacology (3) 3
coffee (3) 3
entry factor (3) 3
expression (3) 3
hcv (3) 3
hepatocyte (3) 3
infection (3) 3
infectious diseases (3) 3
animals (2) 2
antiviral agents (2) 2
caffeic acids - pharmacology (2) 2
cd81 (2) 2
cell line, tumor (2) 2
chlorogenic acid (2) 2
claudin-1 - immunology (2) 2
density-lipoprotein (2) 2
digestive system diseases (2) 2
hepatitis c (2) 2
hepatocellular carcinoma (2) 2
hepatocytes (2) 2
infectivity (2) 2
life-cycle (2) 2
mice (2) 2
monoclonal antibodies (2) 2
multiplication (2) 2
receptor (2) 2
virus internalization - drug effects (2) 2
virus replication (2) 2
virus replication - drug effects (2) 2
virus-cell interactions (2) 2
acids (1) 1
adaptive mutation (1) 1
antibodies (1) 1
antibodies, monoclonal - genetics (1) 1
antibodies, monoclonal - immunology (1) 1
antibodies, monoclonal - isolation & purification (1) 1
antibodies, monoclonal - pharmacology (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibody engineering (1) 1
antibody-dependent cellular cytotoxicity (1) 1
antiviral (1) 1
antiviral agents - pharmacokinetics (1) 1
antiviral agents - therapeutic use (1) 1
apolipoprotein e (1) 1
apolipoproteins (1) 1
architecture (1) 1
association (1) 1
barrier (1) 1
biotechnology & applied microbiology (1) 1
bunyaviridae (1) 1
bunyaviridae infections - drug therapy (1) 1
bunyaviridae infections - virology (1) 1
caco-2 cells (1) 1
caffeic acids - therapeutic use (1) 1
candidate receptor (1) 1
capacity (1) 1
chemical penetration enhancers (1) 1
cholesterol - biosynthesis (1) 1
claudin-1 - antagonists & inhibitors (1) 1
claudin-1 - metabolism (1) 1
claudin-4 - metabolism (1) 1
clostridium-perfringens enterotoxin (1) 1
clustered regularly interspaced short palindromic repeats (1) 1
coffee - chemistry (1) 1
cohort (1) 1
complete replication (1) 1
coumaric acid (1) 1
culture (1) 1
culture-adaptive mutations (1) 1
disease (1) 1
disease models, animal (1) 1
drinking (1) 1
drug-related side effects and adverse reactions (1) 1
edible oils or fats, e.g. margarines, shortenings, cookingoils (1) 1
electrical-resistance (1) 1
entry (1) 1
enzyme inhibitors - pharmacology (1) 1
epidermis - metabolism (1) 1
epithelial cells - metabolism (1) 1
extracellular loop (1) 1
fab neutralizes (1) 1
farnesyl-diphosphate farnesyltransferase - antagonists & inhibitors (1) 1
foods or foodstuffs (1) 1
gene expression (1) 1
genetic engineering (1) 1
genetically modified organisms (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2016, Volume 39, Issue 5, pp. 839 - 848
It is well known that occludin (OCLN) is involved in hepatitis C virus (HCV) entry into hepatocytes, but there has been no conclusive evidence that OCLN is... 
hepatitis C virus | occludin | hepatocyte | Hepatocyte | Hepatitis C virus | Occludin | Occludin - genetics | Cell Line | Virus Replication | Humans | Clustered Regularly Interspaced Short Palindromic Repeats | Hepacivirus - physiology | Hepatitis C | Virus Internalization | Index Medicus
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 05/2019, Volume 42, Issue 5, pp. 770 - 777
Previously, we reported that coffee extract and its constituents, caffeic acid (CA) and p-coumaric acid, inhibit infection by the hepatitis C virus (HCV). In... 
CAPACITY | INTERFERON | MULTIPLICATION | HUMAN APOLIPOPROTEIN-E | hepatitis C virus | apolipoprotein E | PHARMACOLOGY & PHARMACY | tannic acid | HCV | caffeic acid | Tannic acid | p-Coumaric acid | Viruses | Infections | Ribonucleic acid--RNA | Coffee | Apolipoproteins | Caffeic acid | Coumaric acid | Hepatitis | Acids | Apolipoprotein E | Life cycle analysis | Infectivity | Replication | Hepatitis C virus | Hepatitis C
Journal Article
Journal of biochemistry, ISSN 0021-924X, 05/2019
The tight junction protein occludin (OCLN) is a four-pass transmembrane protein with two extracellular loops (ELs), and also functions as a co-receptor for... 
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 06/2019, Volume 514, Issue 3, pp. 785 - 790
Occludin (OCLN), an integral tetra-spanning plasma membrane protein, is a host entry factor essential for hepatitis C virus (HCV) infection, making it a... 
Monoclonal antibody | Antibody engineering | Hepatitis C virus | Antibody-dependent cellular cytotoxicity | Occludin | Virus diseases | Prevention | Antiviral agents | Genetically modified organisms | Monoclonal antibodies | Genetic engineering | Health aspects | Cells
Journal Article
Japanese Journal of Infectious Diseases, ISSN 1344-6304, 2015, Volume 68, Issue 4, pp. 268 - 275
Journal Article
Journal of Virology, ISSN 0022-538X, 04/2018, Volume 92, Issue 8, p. e02258-17
Hepatitis C virus (HCV) entry into host cells is a multistep process requiring various host factors, including the tight junction protein occludin (OCLN),... 
Monoclonal antibodies | Antiviral agents | Hepatitis C virus | Occludin | CELLS | B TYPE-I | antiviral agents | HOST FACTORS | RECEPTOR | HUMANIZED MICE | TIGHT JUNCTIONS | occludin | PRIMARY HUMAN HEPATOCYTES | VIROLOGY | ENTRY FACTOR | DENSITY-LIPOPROTEIN | hepatitis C virus | monoclonal antibodies | HCV ENTRY | Index Medicus
Journal Article
Japanese Journal of Infectious Diseases, ISSN 1344-6304, 2014, Volume 68, Issue 2, pp. 81 - 88
An efficient cell culture and infection system for hepatitis C virus (HCV) is useful for analyzing the complete virus life cycle. Human hepatic Huh7.5.1 cells... 
replication | Hepatitis C virus | hepatocytes | INFECTIOUS DISEASES | ENTRY | RNA REPLICATION | CD81 | HOST-CELL | COMPLETE REPLICATION | HCV INFECTION | EXPRESSION | CULTURE | LINES | PROPAGATION | Cell Line | Gene Expression | Virus Replication | Humans | Hepatocytes - virology | Tetraspanin 28 - metabolism | Hepacivirus - physiology | Tetraspanin 28 - genetics | Viral Load | Virus Cultivation - methods | Index Medicus
Journal Article
Journal of General Virology, ISSN 0022-1317, 10/2018, Volume 99, Issue 10, pp. 1407 - 1417
Hepatitis C virus (HCV) infection and propagation in cultured cells have mainly been investigated using the infectious clinical clone JFH1. However, its... 
Thermostability | Hepatitis C virus | Infectivity | Adaptive mutation | ANTIBODIES | REQUIREMENTS | B TYPE-I | thermostability | CULTURE-ADAPTIVE MUTATIONS | HIGH-TITER | REPLICATION | VIROLOGY | VIRAL PARTICLES | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | VIRION-ASSOCIATED CHOLESTEROL | hepatitis C virus | adaptive mutation | INFECTION IN-VITRO | infectivity | ASSOCIATION | Index Medicus
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2016
It is well known that occludin (OCLN) is involved in hepatitis C virus (HCV) entry into hepatocytes, but there has been no conclusive evidence that OCLN is... 
occludin | hepatocyte | hepatitis C virus
Journal Article
Japanese Journal of Infectious Diseases, ISSN 1344-6304, 2015
Based on multipurpose cohort studies, coffee consumption reduces the risk of hepatocellular carcinoma, one of the main causes of which is hepatitis C virus... 
chlorogenic acid | coffee | HCV | caffeic acid | hepatocellular carcinoma
Journal Article
Japanese Journal of Infectious Diseases, ISSN 1344-6304, 2015, Volume 68, Issue 2, pp. 81 - 88
An efficient cell culture and infection system for hepatitis C virus (HCV) facilitates analyses of the complete virus life cycle. Human hepatic Huh7.5.1 cells... 
replication | hepatitis C virus | hepatocytes
Journal Article
09/2000, 7
PROBLEM TO BE SOLVED: To obtain a colza oil having improved oxidation stability and controlled emission of heating smell by using a specific colza seed as a... 
HUMAN NECESSITIES | EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKINGOILS | FOODS OR FOODSTUFFS | THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Patent
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.